Targeted therapeutic nanotubes influence the viscoelasticity of cancer cells to overcome drug resistance.
Targeted therapeutic nanotubes influence the viscoelasticity of cancer cells to overcome drug resistance.
复制标题
DOI:
10.1021/nn501223q
复制
发表时间:
2014-05-27
期刊:
影响因子:
17.1
通讯作者:
Chen, Xiaoyuan
中科院分区:
文献类型:
--
作者:
Bhirde, Ashwinkumar A.;Chikkaveeraiah, Bhaskara V.;Srivatsan, Avinash;Niu, Gang;Jin, Albert J.;Kapoor, Ankur;Wang, Zhe;Patel, Sachin;Patel, Vyomesh;Gorbach, Alexander M.;Leapman, Richard D.;Gutkind, J. Silvio;Walker, Angela R. Hight;Chen, Xiaoyuan
关键词:
Resistance to chemotherapy is the primary cause of treatment failure in over 90% of cancer patients in the clinic. Research in nanotechnology-based therapeutic alternatives has helped provide innovative and promising strategies to overcome multidrug resistance (MDR). By targeting CD44-overexpressing MDR cancer cells, we have developed in a single-step a self-assembled, self-targetable, therapeutic semiconducting single-walled carbon nanotube (sSWCNT) drug delivery system that can deliver chemotherapeutic agents to both drug-sensitive OVCAR8 and resistant OVCAR8/ADR cancer cells. The novel nanoformula with a cholanic acid-derivatized hyaluronic acid (CAHA) biopolymer wrapped around a sSWCNT and loaded with doxorubicin (DOX), CAHA-sSWCNT-DOX, is much more effective in killing drug-resistant cancer cells compared to the free DOX and phospholipid PEG (PL-PEG)-modified sSWCNT formula, PEG-sSWCNT-DOX. The CAHA-sSWCNT-DOX affects the viscoelastic property more than free DOX and PL-PEG-sSWCNT-DOX, which in turn allows more drug molecules to be internalized. Intravenous injection of CAHA-sSWCNT-DOX (12 mg/kg DOX equivalent) followed by 808 nm laser irradiation (1 W/cm2, 90 s) led to complete tumor eradication in a subcutaneous OVCAR8/ADR drug-resistant xenograft model, while free DOX alone failed to delay tumor growth. Our newly developed CAHA-sSWCNT-DOX nanoformula, which delivers therapeutics and acts as a sensitizer to influence drug uptake and induce apoptosis with minimal resistance factor, provides a novel effective means of counteracting the phenomenon of multidrug resistance.
登录
查看更多内容
DOI:
10.2217/nnm.10.133
发表时间:
2011-04
期刊:
Nanomedicine (London, England)
影响因子:
--
作者:
Huang HC;Yang Y;Nanda A;Koria P;Rege K
通讯作者:
Rege K
影响因子:
17.1
作者:
Bhirde, Ashwin A.;Patel, Vyomesh;Gavard, Julie;Zhang, Guofeng;Sousa, Alioscka A.;Masedunskas, Andrius;Leapman, Richard D.;Weigert, Roberto;Gutkind, J. Silvio;Rusling, James F.
通讯作者:
Rusling, James F.
DOI:
10.2217/nnm.10.90
发表时间:
2010-12
期刊:
Nanomedicine (London, England)
影响因子:
--
作者:
Bhirde AA;Patel S;Sousa AA;Patel V;Molinolo AA;Ji Y;Leapman RD;Gutkind JS;Rusling JF
通讯作者:
Rusling JF
影响因子:
15
作者:
Liang, Shuai;Zhao, Yuming;Adronov, Alex
通讯作者:
Adronov, Alex
影响因子:
12.6
作者:
Chen, Jennifer Y.;Shahid, Ammar;Xi, Jun
通讯作者:
Xi, Jun